New Day Diagnostics LLC
Records under this name other than the patents New Day Diagnostics LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Back to New Day Diagnostics LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,771,939 | Method for Methylation Analysis of Nucleic Acid Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 8,753,810 | Method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids Lapsed on the fee record Ended Jun 17, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 17, 2026 | From the USPTO record |
| US 11,345,966 | Methods for detecting CpG methylation and for diagnosing cancer Lapsed on the fee record Ended May 31, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2026 | From the USPTO record |
| US 9,957,575 | Methods for detecting CpG methylation and for diagnosing cancer Lapsed on the fee record Ended May 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2026 | From the USPTO record |
| US 8,703,414 | Method for the quantification of methylated DNA Lapsed on the fee record Ended Apr 22, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2026 | From the USPTO record |
| US 8,900,829 | Methods and nucleic acids for analyses of cellular proliferative disorders Term ended Term ended Apr 17, 2026 · From the USPTO record | Term ended | Term ended Apr 17, 2026 | From the USPTO record |
| US 9,939,441 | Methods and nucleic acids for analyses for cellular proliferative disorders Lapsed on the fee record Ended Apr 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 10, 2026 | From the USPTO record |
| US 8,679,745 | Method for providing DNA fragments derived from an archived sample Lapsed on the fee record Ended Mar 25, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 25, 2026 | From the USPTO record |
| US 11,261,499 | Methods and Nucleic Acids for Determining the Prognosis of a Cancer Subject Lapsed on the fee record Ended Mar 1, 2026 · High confidence | Lapsed on the fee record | Ended Mar 1, 2026 | High confidence |
| US 8,623,599 | Method for methylation analysis Lapsed on the fee record Ended Jan 7, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2026 | From the USPTO record |